NASDAQ:PETS PetMed Express Q3 2025 Earnings Report $3.09 +0.05 (+1.64%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$3.05 -0.04 (-1.29%) As of 04/17/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Earnings HistoryForecast PetMed Express EPS ResultsActual EPS-$0.03Consensus EPS -$0.01Beat/MissMissed by -$0.02One Year Ago EPSN/APetMed Express Revenue ResultsActual RevenueN/AExpected Revenue$60.00 millionBeat/MissN/AYoY Revenue GrowthN/APetMed Express Announcement DetailsQuarterQ3 2025Date2/10/2025TimeAfter Market ClosesConference Call DateMonday, February 10, 2025Conference Call Time4:30PM ETUpcoming EarningsPetMed Express' Q4 2025 earnings is scheduled for Monday, April 21, 2025Conference Call ResourcesConference Call AudioConference Call TranscriptPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by PetMed Express Q3 2025 Earnings Call TranscriptProvided by QuartrFebruary 10, 2025 ShareLink copied to clipboard.PresentationSkip to Participants Operator00:00:00Greetings and welcome to PetMed Express's Third Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Reed Anderson with ICR. Operator00:00:17You may begin. Reed AndersonManaging Director at ICR00:00:20Thank you, and welcome to the PetMed Xpress fiscal third quarter twenty twenty five earnings conference call. Certain information included during this call may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Securities Exchange Act of 1934 as amended that may involve a number of risks and uncertainties. These statements are based on our beliefs as well as assumptions we have used based on information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions. Actual results could differ materially from those projected. Reed AndersonManaging Director at ICR00:00:56There can be no assurance that any forward looking results will occur or be realized. And nothing contained in this presentation is or should be relied upon as a representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of PetMeds. PetMeds undertakes no obligation to update publicly these forward looking statements based on subsequent events, except as may be required by applicable law, regulation or other competent legal authority. We have identified various risk factors associated with our operations in our most recent annual report and other filings with the Securities and Exchange Commission. Now, let me turn the call over to our CEO and President, Sandra Campos. Reed AndersonManaging Director at ICR00:01:36Sandra? Sandra CamposCEO & President at PetMed Express00:01:38Thank you, Reid, and welcome to everyone joining our call this afternoon. Following my remarks, Robin will provide a detailed overview of our financial results, after which we'll open the lines for your questions. Over the past nine months, I have emphasized that our focus remains steadfast on the strategic initiatives pivotal to repositioning PetMed and PetCareRx for long term success. I have clearly outlined our vision to position pets as a leader in consumer pet healthcare. While we're still in the early stages of this transformation and have much more work ahead, I am pleased to report that we have made significant progress in validating our strategic direction. Sandra CamposCEO & President at PetMed Express00:02:16We're confident that the actions we're taking will drive differentiation and sustainable growth. Our highest priority has been to return the company to profitability. We achieved this by implementing cost cutting measures and consolidation strategies to integrate PetCareRx operations into the PetMeds organization, targeting $5,000,000 in annualized savings and we remain on track to meet this milestone. For this quarter Q3, we achieved $2,000,000 in adjusted EBITDA representing a $1,100,000 improvement year over year while lowering G and A expenses by $2,600,000 compared to last year. As we continue to execute our turnaround strategy, we remain committed to driving shareholder value through growing our customer base, operational discipline and financial efficiency. Sandra CamposCEO & President at PetMed Express00:03:10At Petz, we serve three core communities. First, our pet parents. We're continuously enhancing the digital shopping experience to provide convenient access to pet health solutions. Second, our veterinarian partners. Our investments in Rx approval efficiency through an optimized vet portal are driving increased adoption and streamlined workflows. Sandra CamposCEO & President at PetMed Express00:03:33And third, the pets, dogs, cats and horses that we love and care for. Innovation is at the heart of our approach, ensuring that we offer proven premium health solutions across all categories and life stages. Expanding our customer base and increasing market share remains a top priority. To grow and acquire customers as a digital retailer, we require a modernized tech stack and a seamless shopping experience that meets evolving customer expectations. We have made meaningful progress in this area, including website and mobile enhancements, where we executed a full website refresh in November and also relaunched our iOS and Android mobile apps. Sandra CamposCEO & President at PetMed Express00:04:15We implemented buy now pay later as a new payment option at checkout, expanding on affordable and accessible choices for our consumers. And in collaboration with our veterinary advisory board, we continue to enhance our veterinary portal and also launched pethealthmd.com, an educational platform offering expert backed pet health guidance. These improvements led to 84,000 gross new customers or 63,000 new customers that had orders shipped during the quarter. Our gross order average order value or AOV increased by 7% at $108 versus $101 last year, while our shipped order AOB rose by 4.3% of $97 versus $93 year over year. We are committed to pet health and wellness through product differentiation and best in class customer service. Sandra CamposCEO & President at PetMed Express00:05:13Our SKU optimization strategy ensures that we offer comprehensive health solutions across all life stages, while maintaining strong margins and growth thresholds. To enhance efficiency, we eliminated 4,000 underperforming SKUs, making room for high value products that align with our strategy and also resonate with consumers. Notably, our inventory efficiency has improved with inventory turn rising to 1.5 in Q3 compared to 1.1 in Q2 and 0.9 last year. This improvement comes alongside a 66% reduction in total inventory on hand, totaling $11,800,000 at the end of our third quarter versus $34,600,000 last year. During Q3, we advanced our customer call center operations by integrating an AI driven workforce management tool to flex and scale our agent population and adapt to changing volumes. Sandra CamposCEO & President at PetMed Express00:06:13This helped us improve our key metrics such as increased sales per agent of 18.8 and a 3.4% increase in AOV, average order value, for orders driven by the call center. During our last earnings call, I highlighted our focus on retention and the operational upgrades that laid the foundation for future growth. While we intended to ramp up performance marketing efforts in this quarter, we encountered a highly competitive and promotional holiday environment, particularly between Black Friday and year end. With real time insights, we made the strategic decision to prioritize margin protection over aggressive promotions, ending the quarter with $2,800,000 less in gross advertising spend year over year. As a result, our sales and new customer acquisition during that period fell short of initial expectations. Sandra CamposCEO & President at PetMed Express00:07:07However, this intentional pivot was necessary in order to maintain financial discipline. Recognizing the need for a marketing strategic reset, we are refining our approach to ensure sustainable profitable growth. Our top of funnel initiatives such as radio and connected TV continue to promote our Care You Trust message and establish brand authority and brand awareness. This is a long term investment and we've recently begun and includes things like sports team partnerships, podcasts, billboards and local pet adoption events, all of which we've done in this quarter. We are refining acquisition strategies by rolling out a new email design system and creating stronger segmentation, personalization and dynamic content across our paid platforms. Sandra CamposCEO & President at PetMed Express00:07:54Early indicators show promise with revenue per email increasing 9% in the month of January. Engagement rates have increased quarter over quarter that would be inclusive of open rate, click through rate, revenue per email through stronger content and more relevant branding. We believe this is a strong indicator of future conversion improvements. Beyond customer facing upgrades, we have strengthened our core systems with strategic technology investments to ensure a resilient and secure digital ecosystem for customer data and privacy. Over the past seven months, we resolved OMS issues that previously impacted performance and continue to modernize our tech stack. Sandra CamposCEO & President at PetMed Express00:08:37In mid November, we successfully replatformed our auto ship recurring subscription program without disruption and have seen improvements in auto ship sign ups and credit card rejection rates. Although still in early age tracking, our new website performance shows PDP views increased by 30%, bounce rates declined by 6.5 basis points and channel visits increased 7.6% year over year. This growth in visits was offset by lower conversion and we are actively addressing those conversion rate challenges through search functionality improvements, PDP enhancements and visible promotions. Looking ahead, while the competitive landscape remains dynamic, we are executing a disciplined transformation that prioritizes the customer experience from order placement to last mile delivery, while simultaneously enhancing the infrastructure necessary to support this. We believe these efforts will drive sustained growth, customer loyalty and increased shareholder value. Sandra CamposCEO & President at PetMed Express00:09:40In the short term, we anticipate increased investments to enhance the customer engagement, customer acquisition and the underlying infrastructure needed. We will continue to strengthen vendor partnerships and expand our portfolio with science backed veterinary recommended products across our pharmacy, Rx products, OTC over the counter and our food categories. We remain focused on capturing our share of the companion animal health market by refining our customer experience, optimizing our product mix and strengthening the customer acquisition strategies. As we build a stronger, more efficient organization, we stay true to our core purpose, ensuring pets have homes and live healthier, happier lives. This commitment extends beyond our business as we actively support shelters, facilitate adoption events, and provide aid to pet communities impacted by the LA wildfires, reinforcing our dedication to pet welfare and the people who care for them. Sandra CamposCEO & President at PetMed Express00:10:41With that, I'll turn the call over to Robin for a more detailed review of our financial results. Robyn D’EliaCFO at PetMed Express00:10:47Thank you, Sandra. I will now provide an update on third quarter fiscal year twenty twenty five results for the period ending 12/31/2024. Net sales were $53,000,000 compared to $65,300,000 in the same period last year, a 19% decline primarily driven by a 34% reduction in gross advertising as we rebalanced for profitability. We welcomed approximately 63,000 new customers who received an order from us this quarter. Gross profit was $14,900,000 versus $17,900,000 last year. Robyn D’EliaCFO at PetMed Express00:11:28As a percent of sales, gross profit this year was 28.1%, an 80 basis point improvement compared to the prior year quarter due to a favorable sales mix and lower discount activity similar to what we saw in Q2. General and administrative expenses for the third quarter were $10,800,000 versus $13,400,000 last year, a 19.7% decrease. This year over year improvement was driven by a decrease in stock based compensation expense, a decrease in payroll and payroll related expense and to a lesser extent, a decrease in credit card processing fees driven by lower sales. Our advertising expenses for the third quarter were $3,000,000 compared to $5,800,000 last year. This decrease can be mainly attributed to lower gross media spend and a higher proportion of that spend being funded by third party partners. Robyn D’EliaCFO at PetMed Express00:12:32As Sandra mentioned, we purposely pulled back our marketing efforts to reset our marketing foundation and improve profitability for the quarter. Net loss for the third quarter was $700,000 or $0.03 per diluted share, a meaningful improvement compared to the net loss of $2,000,000 or $0.1 per diluted share for the same period last year. Adjusted EBITDA of $2,000,000 compared to $900,000 in the prior year period. Our balance sheet remains strong. And as of 12/31/2024, we had $50,000,000 of cash and cash equivalents and no debt. Robyn D’EliaCFO at PetMed Express00:13:18We would now like to open the call for questions and then after that Sandra will provide some concluding remarks. Operator? Operator00:13:29Thank you. We will now be conducting a question and answer session. And our first question comes from the line of Erin Wright with Morgan Stanley. Please proceed with your question. Erin WrightAnalyst at Morgan Stanley00:14:00Great. Thanks. I wanted a quick housekeeping one before I get into it. On the new customer or customer account numbers, I guess, do you have I just want to make sure we're comparing apples to apples kind of on a year over year basis, but do you have growth rates around those and how you're kind of defining the different categories from a customer standpoint? Sandra CamposCEO & President at PetMed Express00:14:23From a customer perspective on the new customer, what we shared is that we had 63,000 new customers in this quarter with shift orders, correct. Erin WrightAnalyst at Morgan Stanley00:14:35Okay. Okay. Just wanted to clarify that. And then on the SKU count rationalization, so does that meaningfully impact your overall kind of revenue growth or have you quantified that? I mean, I assume it's underperforming SKUs, but how do we think about that and then also the flow through from a mix perspective? Sandra CamposCEO & President at PetMed Express00:14:54Yes. It actually did not really impact the revenues. A lot of those SKUs happened to be SKUs that were drop shipped from drop ship vendors as well. And so they were not impactful. It was very minimal in terms of any impact over the year. Sandra CamposCEO & President at PetMed Express00:15:09But for the most part, when we look at the SKU optimization, it was about tracking to products that actually had consistent sales over three, four, five and six months time period. So anything beyond that that had not been consistent sales was where we were reducing. So it was definitely not impacting our sales. Erin WrightAnalyst at Morgan Stanley00:15:28Okay, great. And then just thinking about sort of the underlying backdrop in the market, like how do you how would you characterize kind of the trends you are seeing from a customer perspective and how they're responding maybe to price increases across kind of pet prescriptions that we've been seeing and hearing about even year to date and how you're thinking about kind of the outlook of the market, just generally speaking? And then if I could sneak one last one in there, just on the cost savings, obviously, you've executed on that and what's left in terms of the lingering cost savings from the PetRx or PetCareRx transaction? Thanks. Sandra CamposCEO & President at PetMed Express00:16:05Let's start with the second one first. So as we look at our cost optimization and the strategies that we've employed on folding PetCareRx into the organization, we still have more that we are deliberately working on now. And that not only just includes the first phase that we did and executed, which had to do with people, technology, some technology as well as some outsourced agencies that we're reduplicating. But in addition to that now as we go into Phase II and the second part of it, it actually is more of the technology reduction consolidation that actually will continue to show an improved balance in terms of what our expenditures are. Do you want to add anything to Robin? Sandra CamposCEO & President at PetMed Express00:16:50No, that's right. That's right. And it's a strategy that'll take us over a couple of quarters to execute. Sorry, okay. So that was question number two. Sandra CamposCEO & President at PetMed Express00:17:04Going back to question number one, it is without a doubt that the customer continues to be pressured. And as we know, we're seeing a bit more of stabilization as it relates to adoption and pets in general. But we're still seeing that there are reduced visits to the veterinarian. There's some reduced prescriptions. We have not seen our UPTs and Rx and pharmacy actually changed from a year ago. Sandra CamposCEO & President at PetMed Express00:17:29So it's still they're still buying the same amount of times and frequency per year. So it's still about 2.7 times a year that the average prescription they're coming back to get a prescription again and that fluctuates based on seasonality, especially as we talk about a flea and tick season per se. But yes, they are absolutely pressured in terms of where they're spending, how they're spending. And we are seeing a bit more as it relates to opening price points take over some of the more premium price points. That said, we still have a higher household income consumer who spends who has a household income over $100,000 and that $100,000 to $150,000 and $150,000 plus household income is continuing to spend and does not have and is not exhibiting some of the same behavior that other customers are with regards to not being in compliance on the prescription and less spend on their products that relates specifically to pharmacy. Erin WrightAnalyst at Morgan Stanley00:18:28Okay. Thank you. Operator00:18:33Thank you. Our next question comes from the line of Ryan Ayres with Lake Street Capital Markets. Please proceed with your question. Ryan MeyersSenior Research Analyst at Lake Street Capital Markets, LLC00:18:42Hey guys, thanks for taking my questions. And Tanner, this is kind of a follow-up from the last question that you had as far as just what you're seeing across your core consumer and them kind of being a higher household income. But that said, I mean, we've now seen three consecutive quarters of over double digit revenue declines. I know you guys are pulling back a little bit on the marketing spend, which obviously is impacting the revenue growth. But can you kind of talk about what else you're seeing here as far as what's driving the softness? Sandra CamposCEO & President at PetMed Express00:19:10Well, our softness as it relates to where we've been and you've heard me talk about this a bit as well. One of the reasons that we actually modernized our website is because we have not captured a younger, more millennial origin, the consumer. So as we think about not only what's happening from a consumer behavior standpoint, people are taking longer to have children and or their pets are becoming their children and they're spending more on those children or on those pets or their children essentially in the millennial and Gen Z demographic. So we are modernizing, we are fine tuning our messaging, our content, all of the different platforms in which we are competing so that we can actually capture that customer. That's not where we've been as a business over many years. Sandra CamposCEO & President at PetMed Express00:19:57So for us, we're actually transitioning that. And as we transition away from a core customer that may have been a little bit older that's new to one-eight hundred PetMed brand, because of all of those many years, obviously twenty eight years worth of great heritage the company has had, we're trying to also make sure that we're capturing the millennial and Gen Z consumer who is spending, who is focused on more digital experiences, who is buying online, is accustomed to it and that's what you're seeing now. As we've repositioned our marketing and the efforts on marketing that goes into content, it goes into the different channels in which we show up and we know and understand that this is going to take and require multiple touch points that the consumer is going to see our brands before they actually start to engage and then convert. Ryan MeyersSenior Research Analyst at Lake Street Capital Markets, LLC00:20:47Got it. And then as we think about the rest of this year and into next year, when you guys are well capitalized with $50,000,000 of cash on the balance sheet, I mean, how are you evaluating potentially investing more heavily into marketing, kind of running more promotions really to try to drive revenue growth back into the business or even just new customer growth back into the business? Any commentary there would be helpful. Sandra CamposCEO & President at PetMed Express00:21:11Yes. We definitely think about capital allocation and of course how to drive our transformation faster. As Sandra mentioned, right on the marketing front, we are resetting, I would say that the marketing foundation. So we want to do it in a way that's smart, that's going to be the most beneficial in terms of the ROI. We have to kind of set the foundation and get ready to go. Sandra CamposCEO & President at PetMed Express00:21:34Additionally, we're investing in our customer experience. It's critically important that we have the right product assortment. We can get to the customer faster and that the customers have ease of use on our site. And so we're going to continue to make those foundational investments. And then we can really, I would say, open the floodgates to some extent, right, and start spending more heavily in the marketing area. Sandra CamposCEO & President at PetMed Express00:22:01And Ryan, I would just add to what Robin said, just to double click on this point. In order for us to be competitive in today's environment and the consumer expectation is that you're going to get product same day, next day or within two days. And so she was just mentioning last mile delivery as another key target, key focus area for us. We are focused on that customer experience, which has so many different legs to this and we need to make sure that we are delivering on a timely basis as well. So those investments are coming. Sandra CamposCEO & President at PetMed Express00:22:31We're actually investing in that in this quarter of Q4 as well as starting to increase more on marketing as we go forward. Ryan MeyersSenior Research Analyst at Lake Street Capital Markets, LLC00:22:41Great. Thanks for taking my questions. Operator00:22:47Thank you. And this concludes, we have reached the end of the question and answer session. I'll now turn the call back over to CEO, Sandra Campos for closing remarks. Sandra CamposCEO & President at PetMed Express00:23:02Thank you. And thanks for the questions, for the time and the support of Petmed. We understand that this is a transformation on many levels. It is steady and the key initiatives that we discussed today are about prioritizing profitability and the customer growth. Lastly, I just want to thank all of our employees for their constant commitment and the dedication to our customers, the pets that we serve and to our shareholders. Sandra CamposCEO & President at PetMed Express00:23:24So we look forward to continuing to update you on our progress during our next conference call. Thank you. Operator00:23:32Thank you. This does conclude today's conference. You may disconnect your lines at this time. Thank you for your participation.Read moreParticipantsExecutivesSandra CamposCEO & PresidentRobyn D’EliaCFOAnalystsReed AndersonManaging Director at ICRErin WrightAnalyst at Morgan StanleyRyan MeyersSenior Research Analyst at Lake Street Capital Markets, LLCPowered by Conference Call Audio Live Call not available Earnings Conference CallPetMed Express Q3 202500:00 / 00:00Speed:1x1.25x1.5x2xTranscript SectionsPresentationParticipants Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) PetMed Express Earnings HeadlinesPetMed Express price target lowered to $3.20 from $3.50 at Morgan StanleyApril 18 at 2:16 AM | markets.businessinsider.comMorgan Stanley Sticks to Their Sell Rating for Petmed Express (PETS)April 18 at 2:16 AM | markets.businessinsider.comTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionApril 18, 2025 | Crypto 101 Media (Ad)LIVE: PetMed Express, Inc. Rings the Opening BellApril 13, 2025 | nasdaq.comPetMed Express adds new director, Dr. Fulgoni to retireApril 11, 2025 | uk.investing.comPetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11thApril 11, 2025 | globenewswire.comSee More PetMed Express Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PetMed Express? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetMed Express and other key companies, straight to your email. Email Address About PetMed ExpressPetMed Express (NASDAQ:PETS), together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.View PetMed Express ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth Ahead Upcoming Earnings Tesla (4/22/2025)Intuitive Surgical (4/22/2025)Verizon Communications (4/22/2025)Canadian National Railway (4/22/2025)Novartis (4/22/2025)RTX (4/22/2025)3M (4/22/2025)Capital One Financial (4/22/2025)General Electric (4/22/2025)Danaher (4/22/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PresentationSkip to Participants Operator00:00:00Greetings and welcome to PetMed Express's Third Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Reed Anderson with ICR. Operator00:00:17You may begin. Reed AndersonManaging Director at ICR00:00:20Thank you, and welcome to the PetMed Xpress fiscal third quarter twenty twenty five earnings conference call. Certain information included during this call may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Securities Exchange Act of 1934 as amended that may involve a number of risks and uncertainties. These statements are based on our beliefs as well as assumptions we have used based on information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions. Actual results could differ materially from those projected. Reed AndersonManaging Director at ICR00:00:56There can be no assurance that any forward looking results will occur or be realized. And nothing contained in this presentation is or should be relied upon as a representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of PetMeds. PetMeds undertakes no obligation to update publicly these forward looking statements based on subsequent events, except as may be required by applicable law, regulation or other competent legal authority. We have identified various risk factors associated with our operations in our most recent annual report and other filings with the Securities and Exchange Commission. Now, let me turn the call over to our CEO and President, Sandra Campos. Reed AndersonManaging Director at ICR00:01:36Sandra? Sandra CamposCEO & President at PetMed Express00:01:38Thank you, Reid, and welcome to everyone joining our call this afternoon. Following my remarks, Robin will provide a detailed overview of our financial results, after which we'll open the lines for your questions. Over the past nine months, I have emphasized that our focus remains steadfast on the strategic initiatives pivotal to repositioning PetMed and PetCareRx for long term success. I have clearly outlined our vision to position pets as a leader in consumer pet healthcare. While we're still in the early stages of this transformation and have much more work ahead, I am pleased to report that we have made significant progress in validating our strategic direction. Sandra CamposCEO & President at PetMed Express00:02:16We're confident that the actions we're taking will drive differentiation and sustainable growth. Our highest priority has been to return the company to profitability. We achieved this by implementing cost cutting measures and consolidation strategies to integrate PetCareRx operations into the PetMeds organization, targeting $5,000,000 in annualized savings and we remain on track to meet this milestone. For this quarter Q3, we achieved $2,000,000 in adjusted EBITDA representing a $1,100,000 improvement year over year while lowering G and A expenses by $2,600,000 compared to last year. As we continue to execute our turnaround strategy, we remain committed to driving shareholder value through growing our customer base, operational discipline and financial efficiency. Sandra CamposCEO & President at PetMed Express00:03:10At Petz, we serve three core communities. First, our pet parents. We're continuously enhancing the digital shopping experience to provide convenient access to pet health solutions. Second, our veterinarian partners. Our investments in Rx approval efficiency through an optimized vet portal are driving increased adoption and streamlined workflows. Sandra CamposCEO & President at PetMed Express00:03:33And third, the pets, dogs, cats and horses that we love and care for. Innovation is at the heart of our approach, ensuring that we offer proven premium health solutions across all categories and life stages. Expanding our customer base and increasing market share remains a top priority. To grow and acquire customers as a digital retailer, we require a modernized tech stack and a seamless shopping experience that meets evolving customer expectations. We have made meaningful progress in this area, including website and mobile enhancements, where we executed a full website refresh in November and also relaunched our iOS and Android mobile apps. Sandra CamposCEO & President at PetMed Express00:04:15We implemented buy now pay later as a new payment option at checkout, expanding on affordable and accessible choices for our consumers. And in collaboration with our veterinary advisory board, we continue to enhance our veterinary portal and also launched pethealthmd.com, an educational platform offering expert backed pet health guidance. These improvements led to 84,000 gross new customers or 63,000 new customers that had orders shipped during the quarter. Our gross order average order value or AOV increased by 7% at $108 versus $101 last year, while our shipped order AOB rose by 4.3% of $97 versus $93 year over year. We are committed to pet health and wellness through product differentiation and best in class customer service. Sandra CamposCEO & President at PetMed Express00:05:13Our SKU optimization strategy ensures that we offer comprehensive health solutions across all life stages, while maintaining strong margins and growth thresholds. To enhance efficiency, we eliminated 4,000 underperforming SKUs, making room for high value products that align with our strategy and also resonate with consumers. Notably, our inventory efficiency has improved with inventory turn rising to 1.5 in Q3 compared to 1.1 in Q2 and 0.9 last year. This improvement comes alongside a 66% reduction in total inventory on hand, totaling $11,800,000 at the end of our third quarter versus $34,600,000 last year. During Q3, we advanced our customer call center operations by integrating an AI driven workforce management tool to flex and scale our agent population and adapt to changing volumes. Sandra CamposCEO & President at PetMed Express00:06:13This helped us improve our key metrics such as increased sales per agent of 18.8 and a 3.4% increase in AOV, average order value, for orders driven by the call center. During our last earnings call, I highlighted our focus on retention and the operational upgrades that laid the foundation for future growth. While we intended to ramp up performance marketing efforts in this quarter, we encountered a highly competitive and promotional holiday environment, particularly between Black Friday and year end. With real time insights, we made the strategic decision to prioritize margin protection over aggressive promotions, ending the quarter with $2,800,000 less in gross advertising spend year over year. As a result, our sales and new customer acquisition during that period fell short of initial expectations. Sandra CamposCEO & President at PetMed Express00:07:07However, this intentional pivot was necessary in order to maintain financial discipline. Recognizing the need for a marketing strategic reset, we are refining our approach to ensure sustainable profitable growth. Our top of funnel initiatives such as radio and connected TV continue to promote our Care You Trust message and establish brand authority and brand awareness. This is a long term investment and we've recently begun and includes things like sports team partnerships, podcasts, billboards and local pet adoption events, all of which we've done in this quarter. We are refining acquisition strategies by rolling out a new email design system and creating stronger segmentation, personalization and dynamic content across our paid platforms. Sandra CamposCEO & President at PetMed Express00:07:54Early indicators show promise with revenue per email increasing 9% in the month of January. Engagement rates have increased quarter over quarter that would be inclusive of open rate, click through rate, revenue per email through stronger content and more relevant branding. We believe this is a strong indicator of future conversion improvements. Beyond customer facing upgrades, we have strengthened our core systems with strategic technology investments to ensure a resilient and secure digital ecosystem for customer data and privacy. Over the past seven months, we resolved OMS issues that previously impacted performance and continue to modernize our tech stack. Sandra CamposCEO & President at PetMed Express00:08:37In mid November, we successfully replatformed our auto ship recurring subscription program without disruption and have seen improvements in auto ship sign ups and credit card rejection rates. Although still in early age tracking, our new website performance shows PDP views increased by 30%, bounce rates declined by 6.5 basis points and channel visits increased 7.6% year over year. This growth in visits was offset by lower conversion and we are actively addressing those conversion rate challenges through search functionality improvements, PDP enhancements and visible promotions. Looking ahead, while the competitive landscape remains dynamic, we are executing a disciplined transformation that prioritizes the customer experience from order placement to last mile delivery, while simultaneously enhancing the infrastructure necessary to support this. We believe these efforts will drive sustained growth, customer loyalty and increased shareholder value. Sandra CamposCEO & President at PetMed Express00:09:40In the short term, we anticipate increased investments to enhance the customer engagement, customer acquisition and the underlying infrastructure needed. We will continue to strengthen vendor partnerships and expand our portfolio with science backed veterinary recommended products across our pharmacy, Rx products, OTC over the counter and our food categories. We remain focused on capturing our share of the companion animal health market by refining our customer experience, optimizing our product mix and strengthening the customer acquisition strategies. As we build a stronger, more efficient organization, we stay true to our core purpose, ensuring pets have homes and live healthier, happier lives. This commitment extends beyond our business as we actively support shelters, facilitate adoption events, and provide aid to pet communities impacted by the LA wildfires, reinforcing our dedication to pet welfare and the people who care for them. Sandra CamposCEO & President at PetMed Express00:10:41With that, I'll turn the call over to Robin for a more detailed review of our financial results. Robyn D’EliaCFO at PetMed Express00:10:47Thank you, Sandra. I will now provide an update on third quarter fiscal year twenty twenty five results for the period ending 12/31/2024. Net sales were $53,000,000 compared to $65,300,000 in the same period last year, a 19% decline primarily driven by a 34% reduction in gross advertising as we rebalanced for profitability. We welcomed approximately 63,000 new customers who received an order from us this quarter. Gross profit was $14,900,000 versus $17,900,000 last year. Robyn D’EliaCFO at PetMed Express00:11:28As a percent of sales, gross profit this year was 28.1%, an 80 basis point improvement compared to the prior year quarter due to a favorable sales mix and lower discount activity similar to what we saw in Q2. General and administrative expenses for the third quarter were $10,800,000 versus $13,400,000 last year, a 19.7% decrease. This year over year improvement was driven by a decrease in stock based compensation expense, a decrease in payroll and payroll related expense and to a lesser extent, a decrease in credit card processing fees driven by lower sales. Our advertising expenses for the third quarter were $3,000,000 compared to $5,800,000 last year. This decrease can be mainly attributed to lower gross media spend and a higher proportion of that spend being funded by third party partners. Robyn D’EliaCFO at PetMed Express00:12:32As Sandra mentioned, we purposely pulled back our marketing efforts to reset our marketing foundation and improve profitability for the quarter. Net loss for the third quarter was $700,000 or $0.03 per diluted share, a meaningful improvement compared to the net loss of $2,000,000 or $0.1 per diluted share for the same period last year. Adjusted EBITDA of $2,000,000 compared to $900,000 in the prior year period. Our balance sheet remains strong. And as of 12/31/2024, we had $50,000,000 of cash and cash equivalents and no debt. Robyn D’EliaCFO at PetMed Express00:13:18We would now like to open the call for questions and then after that Sandra will provide some concluding remarks. Operator? Operator00:13:29Thank you. We will now be conducting a question and answer session. And our first question comes from the line of Erin Wright with Morgan Stanley. Please proceed with your question. Erin WrightAnalyst at Morgan Stanley00:14:00Great. Thanks. I wanted a quick housekeeping one before I get into it. On the new customer or customer account numbers, I guess, do you have I just want to make sure we're comparing apples to apples kind of on a year over year basis, but do you have growth rates around those and how you're kind of defining the different categories from a customer standpoint? Sandra CamposCEO & President at PetMed Express00:14:23From a customer perspective on the new customer, what we shared is that we had 63,000 new customers in this quarter with shift orders, correct. Erin WrightAnalyst at Morgan Stanley00:14:35Okay. Okay. Just wanted to clarify that. And then on the SKU count rationalization, so does that meaningfully impact your overall kind of revenue growth or have you quantified that? I mean, I assume it's underperforming SKUs, but how do we think about that and then also the flow through from a mix perspective? Sandra CamposCEO & President at PetMed Express00:14:54Yes. It actually did not really impact the revenues. A lot of those SKUs happened to be SKUs that were drop shipped from drop ship vendors as well. And so they were not impactful. It was very minimal in terms of any impact over the year. Sandra CamposCEO & President at PetMed Express00:15:09But for the most part, when we look at the SKU optimization, it was about tracking to products that actually had consistent sales over three, four, five and six months time period. So anything beyond that that had not been consistent sales was where we were reducing. So it was definitely not impacting our sales. Erin WrightAnalyst at Morgan Stanley00:15:28Okay, great. And then just thinking about sort of the underlying backdrop in the market, like how do you how would you characterize kind of the trends you are seeing from a customer perspective and how they're responding maybe to price increases across kind of pet prescriptions that we've been seeing and hearing about even year to date and how you're thinking about kind of the outlook of the market, just generally speaking? And then if I could sneak one last one in there, just on the cost savings, obviously, you've executed on that and what's left in terms of the lingering cost savings from the PetRx or PetCareRx transaction? Thanks. Sandra CamposCEO & President at PetMed Express00:16:05Let's start with the second one first. So as we look at our cost optimization and the strategies that we've employed on folding PetCareRx into the organization, we still have more that we are deliberately working on now. And that not only just includes the first phase that we did and executed, which had to do with people, technology, some technology as well as some outsourced agencies that we're reduplicating. But in addition to that now as we go into Phase II and the second part of it, it actually is more of the technology reduction consolidation that actually will continue to show an improved balance in terms of what our expenditures are. Do you want to add anything to Robin? Sandra CamposCEO & President at PetMed Express00:16:50No, that's right. That's right. And it's a strategy that'll take us over a couple of quarters to execute. Sorry, okay. So that was question number two. Sandra CamposCEO & President at PetMed Express00:17:04Going back to question number one, it is without a doubt that the customer continues to be pressured. And as we know, we're seeing a bit more of stabilization as it relates to adoption and pets in general. But we're still seeing that there are reduced visits to the veterinarian. There's some reduced prescriptions. We have not seen our UPTs and Rx and pharmacy actually changed from a year ago. Sandra CamposCEO & President at PetMed Express00:17:29So it's still they're still buying the same amount of times and frequency per year. So it's still about 2.7 times a year that the average prescription they're coming back to get a prescription again and that fluctuates based on seasonality, especially as we talk about a flea and tick season per se. But yes, they are absolutely pressured in terms of where they're spending, how they're spending. And we are seeing a bit more as it relates to opening price points take over some of the more premium price points. That said, we still have a higher household income consumer who spends who has a household income over $100,000 and that $100,000 to $150,000 and $150,000 plus household income is continuing to spend and does not have and is not exhibiting some of the same behavior that other customers are with regards to not being in compliance on the prescription and less spend on their products that relates specifically to pharmacy. Erin WrightAnalyst at Morgan Stanley00:18:28Okay. Thank you. Operator00:18:33Thank you. Our next question comes from the line of Ryan Ayres with Lake Street Capital Markets. Please proceed with your question. Ryan MeyersSenior Research Analyst at Lake Street Capital Markets, LLC00:18:42Hey guys, thanks for taking my questions. And Tanner, this is kind of a follow-up from the last question that you had as far as just what you're seeing across your core consumer and them kind of being a higher household income. But that said, I mean, we've now seen three consecutive quarters of over double digit revenue declines. I know you guys are pulling back a little bit on the marketing spend, which obviously is impacting the revenue growth. But can you kind of talk about what else you're seeing here as far as what's driving the softness? Sandra CamposCEO & President at PetMed Express00:19:10Well, our softness as it relates to where we've been and you've heard me talk about this a bit as well. One of the reasons that we actually modernized our website is because we have not captured a younger, more millennial origin, the consumer. So as we think about not only what's happening from a consumer behavior standpoint, people are taking longer to have children and or their pets are becoming their children and they're spending more on those children or on those pets or their children essentially in the millennial and Gen Z demographic. So we are modernizing, we are fine tuning our messaging, our content, all of the different platforms in which we are competing so that we can actually capture that customer. That's not where we've been as a business over many years. Sandra CamposCEO & President at PetMed Express00:19:57So for us, we're actually transitioning that. And as we transition away from a core customer that may have been a little bit older that's new to one-eight hundred PetMed brand, because of all of those many years, obviously twenty eight years worth of great heritage the company has had, we're trying to also make sure that we're capturing the millennial and Gen Z consumer who is spending, who is focused on more digital experiences, who is buying online, is accustomed to it and that's what you're seeing now. As we've repositioned our marketing and the efforts on marketing that goes into content, it goes into the different channels in which we show up and we know and understand that this is going to take and require multiple touch points that the consumer is going to see our brands before they actually start to engage and then convert. Ryan MeyersSenior Research Analyst at Lake Street Capital Markets, LLC00:20:47Got it. And then as we think about the rest of this year and into next year, when you guys are well capitalized with $50,000,000 of cash on the balance sheet, I mean, how are you evaluating potentially investing more heavily into marketing, kind of running more promotions really to try to drive revenue growth back into the business or even just new customer growth back into the business? Any commentary there would be helpful. Sandra CamposCEO & President at PetMed Express00:21:11Yes. We definitely think about capital allocation and of course how to drive our transformation faster. As Sandra mentioned, right on the marketing front, we are resetting, I would say that the marketing foundation. So we want to do it in a way that's smart, that's going to be the most beneficial in terms of the ROI. We have to kind of set the foundation and get ready to go. Sandra CamposCEO & President at PetMed Express00:21:34Additionally, we're investing in our customer experience. It's critically important that we have the right product assortment. We can get to the customer faster and that the customers have ease of use on our site. And so we're going to continue to make those foundational investments. And then we can really, I would say, open the floodgates to some extent, right, and start spending more heavily in the marketing area. Sandra CamposCEO & President at PetMed Express00:22:01And Ryan, I would just add to what Robin said, just to double click on this point. In order for us to be competitive in today's environment and the consumer expectation is that you're going to get product same day, next day or within two days. And so she was just mentioning last mile delivery as another key target, key focus area for us. We are focused on that customer experience, which has so many different legs to this and we need to make sure that we are delivering on a timely basis as well. So those investments are coming. Sandra CamposCEO & President at PetMed Express00:22:31We're actually investing in that in this quarter of Q4 as well as starting to increase more on marketing as we go forward. Ryan MeyersSenior Research Analyst at Lake Street Capital Markets, LLC00:22:41Great. Thanks for taking my questions. Operator00:22:47Thank you. And this concludes, we have reached the end of the question and answer session. I'll now turn the call back over to CEO, Sandra Campos for closing remarks. Sandra CamposCEO & President at PetMed Express00:23:02Thank you. And thanks for the questions, for the time and the support of Petmed. We understand that this is a transformation on many levels. It is steady and the key initiatives that we discussed today are about prioritizing profitability and the customer growth. Lastly, I just want to thank all of our employees for their constant commitment and the dedication to our customers, the pets that we serve and to our shareholders. Sandra CamposCEO & President at PetMed Express00:23:24So we look forward to continuing to update you on our progress during our next conference call. Thank you. Operator00:23:32Thank you. This does conclude today's conference. You may disconnect your lines at this time. Thank you for your participation.Read moreParticipantsExecutivesSandra CamposCEO & PresidentRobyn D’EliaCFOAnalystsReed AndersonManaging Director at ICRErin WrightAnalyst at Morgan StanleyRyan MeyersSenior Research Analyst at Lake Street Capital Markets, LLCPowered by